This inventor holds 4 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignee: Zumutor Biologics Inc.. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Uttar Pradesh Aligarh, IN (2022)
- Aligarh, IN (2022 - 2023)
Company Filing History:
Years Active: 2022-2023
Title: Amir Khan - Innovator in Antibody Technology
Introduction
Amir Khan is a prominent inventor based in Aligarh, India, known for his significant contributions to the field of biotechnology. He has been instrumental in developing innovative methods and vectors for cloning and expressing proteins, particularly in the context of antibody technology. With a total of 4 patents to his name, Amir continues to push the boundaries of scientific research and application.
Latest Patents
Amir Khan's latest patents include groundbreaking work on vectors for cloning and expression of proteins. This patent focuses on vectors that facilitate the cloning and expression of genetic material, including antibody genes. The vectors are designed to express these genes in various formats, such as Fab or scFv, utilizing advanced systems like phage display technology. This technology allows for the efficient cloning and screening of potential antibody genes, which are then transferred to yeast vectors for further screening and identification of lead molecules against antigens. The advantages of these vectors include uniquely designed inserts and expression cassettes that enhance the transfer of clonal populations, leading to efficient library preparation and identification of lead molecules.
Another notable patent by Amir involves the generation of an antibody naïve library. This library encompasses a pool of nucleic acid sequences derived from the natural antibody repertoire of healthy and genetically diverse human populations. The method employs a combination of phage and yeast antibody surface display concepts, enabling the screening of large antibody library sizes and facilitating better folding of antibody structures. This innovative approach not only enhances the efficiency of antibody generation but also opens new avenues for therapeutic applications.
Career Highlights
Amir Khan is currently associated with Zumutor Biologics Inc., where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in developing new therapeutic antibodies and improving existing methodologies in protein expression.
Collaborations
Amir collaborates with talented individuals such as Sahana Bhima Rao and Subhra Prakash Chakrabarty, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Amir Khan's contributions to antibody technology and protein expression are noteworthy, showcasing his dedication to advancing scientific knowledge and application. His innovative patents and collaborative efforts position him as a key figure in the biotechnology sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile